Genzyme Corporation et al v. Novartis Gene Therapies, Inc. et al
| Genzyme Corporation and Aventis Inc. |
| Novartis Gene Therapies, Inc., Novartis Pharmaceuticals Corporation and Novartis AG |
| 1:2021cv01736 |
| December 10, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent |
| 35 U.S.C. § 1 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 12, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Pro Hac Vice Attorneys Michael R. Galgano, Cora R. Holt, John D. Livingstone, and Amanda K. Murphy for Novartis AG, Novartis Gene Therapies, Inc.,and Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
|
Filing 16
MOTION for Pro Hac Vice Appearance of Attorney John Livingstone, Amanda Murphy, Ph.D., Cora Holt, and Michael Galgano - filed by Novartis AG, Novartis Gene Therapies, Inc., Novartis Pharmaceuticals Corporation. (Silver, Daniel)
|
|
Pro Hac Vice Attorneys Bryan G. Helwig, Nicole E. Grimm, George T. Lyons, III, Paul H. Berghoff, Joshua R. Rich, and Alexandra E. MacKenzie for Aventis Inc., and Genzyme Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
|
|
Pro Hac Vice Attorney Bryan G. Helwig, Joshua R. Rich, Paul H. Berghoff, Alexandra E. MacKenzie, Nicole E. Grimm, and George T. Lyons, III for Aventis Inc. and Genzyme Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
SO ORDERED, re #16 MOTION for Pro Hac Vice Appearance of Attorney John Livingstone, Amanda Murphy, Ph.D., Cora Holt, and Michael Galgano, filed by Novartis AG, Novartis Pharmaceuticals Corporation, Novartis Gene Therapies, Inc.. Signed by Judge Richard G. Andrews on 1/5/2022. (nms)
|
|
Filing 15
STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to Complaint to April 4, 2022 - filed by Novartis AG, Novartis Gene Therapies, Inc., Novartis Pharmaceuticals Corporation. (Silver, Daniel)
|
|
Filing 14
MOTION for Pro Hac Vice Appearance of Attorney Alexandra E. MacKenzie - filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 13
MOTION for Pro Hac Vice Appearance of Attorney Bryan G. Helwig, Ph.D - filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 12
MOTION for Pro Hac Vice Appearance of Attorney George T. Lyons, III - filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 11
MOTION for Pro Hac Vice Appearance of Attorney Nicole E. Grimm - filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 10
MOTION for Pro Hac Vice Appearance of Attorney Joshua R. Rich - filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 9
MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff - filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 8
WAIVER OF SERVICE returned executed by Genzyme Corporation, Aventis Inc.: For Novartis AG waiver sent on 1/3/2022, answer due 3/4/2022. (Wilks, David)
|
|
SO ORDERED, re #15 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Novartis AG answer due 4/4/2022; Novartis Gene Therapies, Inc. answer due 4/4/2022; Novartis Pharmaceuticals Corporation answer due 4/4/2022). Signed by Judge Richard G. Andrews on 1/4/2022. (nms)
|
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Alexandra E. MacKenzie, filed by Aventis Inc., Genzyme Corporation, #12 MOTION for Pro Hac Vice Appearance of Attorney George T. Lyons, III, filed by Aventis Inc., Genzyme Corporation, #13 MOTION for Pro Hac Vice Appearance of Attorney Bryan G. Helwig, Ph.D, filed by Aventis Inc., Genzyme Corporation, #11 MOTION for Pro Hac Vice Appearance of Attorney Nicole E. Grimm, filed by Aventis Inc., Genzyme Corporation, and #10 MOTION for Pro Hac Vice Appearance of Attorney Joshua R. Rich, filed by Aventis Inc., Genzyme Corporation. Signed by Judge Richard G. Andrews on 1/4/2022. (nms)
|
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, filed by Aventis Inc., Genzyme Corporation. Signed by Judge Richard G. Andrews on 1/4/2022. (nms)
|
|
Filing 7
NOTICE of Appearance by Daniel M. Silver on behalf of Novartis AG, Novartis Gene Therapies, Inc., Novartis Pharmaceuticals Corporation (Silver, Daniel)
|
|
Filing 6
SUMMONS Returned Executed by Genzyme Corporation, Aventis Inc.. Novartis Pharmaceuticals Corporation served on 12/15/2021, answer due 1/5/2022. (Wilks, David)
|
|
Filing 5
SUMMONS Returned Executed by Genzyme Corporation, Aventis Inc.. Novartis Gene Therapies, Inc. served on 12/15/2021, answer due 1/5/2022. (Wilks, David)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,596,535 ;7,125,717 ;7,785,888 ;7,846,729 ;8,093,054. (nmg)
|
|
Filing 3
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventis Inc., Genzyme Corporation filed by Aventis Inc., Genzyme Corporation. (Wilks, David)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
|
|
Filing 1
COMPLAINT filed with Jury Demand against Novartis AG, Novartis Gene Therapies, Inc., Novartis Pharmaceuticals Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3760297.) - filed by Genzyme Corporation, Aventis Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Civil Cover Sheet)(myr)
|
|
No Summons Issued. (myr)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
